MaxCyte Correlations

MXCT Stock  USD 1.55  0.01  0.65%   
The current 90-days correlation between MaxCyte and TriSalus Life Sciences is 0.23 (i.e., Modest diversification). The correlation of MaxCyte is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

MaxCyte Correlation With Market

Modest diversification

The correlation between MaxCyte and DJI is 0.29 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding MaxCyte and DJI in the same portfolio, assuming nothing else is changed.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MaxCyte. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in private.
For more information on how to buy MaxCyte Stock please use our How to Invest in MaxCyte guide.

Moving against MaxCyte Stock

  0.79SNN Smith Nephew SNATSPairCorr
  0.73GENI Genius SportsPairCorr
  0.71HLIO Helios TechnologiesPairCorr
  0.61VWAGY Volkswagen AG 110 Earnings Call TomorrowPairCorr
  0.58VLKAF Volkswagen AG Earnings Call TomorrowPairCorr
  0.48VLKPF Volkswagen AG VZOPairCorr
  0.34SAR Saratoga Investment Corp Normal TradingPairCorr
  0.33HNHPF Hon Hai PrecisionPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

OWLTPRE
FBRXHYPR
FBRXPRE
PREAVR
OWLTPROF
FBRXOWLT
  

High negative correlations

ATLNPROF
ATLNRPID
RPIDSGHT
RPIDTLSI
PROFTLSI
HYPRSGHT

Risk-Adjusted Indicators

There is a big difference between MaxCyte Stock performing well and MaxCyte Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze MaxCyte's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
TLSI  3.10 (0.01) 0.03  0.08  3.41 
 7.63 
 26.13 
PROF  3.62  0.09  0.03  0.13  5.12 
 11.76 
 29.14 
SGHT  3.29  0.44  0.24  0.23  2.12 
 8.11 
 38.03 
HYPR  4.73  0.14  0.05  0.13  7.30 
 14.17 
 56.97 
AVR  4.91  0.47  0.13  0.25  4.64 
 11.54 
 32.32 
RPID  4.10 (0.62) 0.00 (0.15) 0.00 
 8.58 
 23.32 
PRE  4.32  0.95  0.12 (0.46) 5.18 
 10.70 
 38.03 
OWLT  3.69  0.25  0.06  0.31  4.33 
 9.50 
 28.94 
FBRX  3.62  0.23  0.06  0.32  3.85 
 9.07 
 22.83 
ATLN  7.63  0.80  0.15  0.25  6.98 
 26.49 
 61.66 

MaxCyte Corporate Management

James BradySenior SupportProfile
Stark ThompsonConsultantProfile
Jill MayerSenior ResourcesProfile
Cenk SumenChief OfficerProfile
Douglas DoerflerPresident, FounderProfile
Jay GelfmanSenior OperationsProfile